Objectives: The increase in infections as a result of MDR strains of Escherichia coli is a global health crisis. The emergence of globally disseminated lineages of E. coli carrying ESBL genes has been well characterized. An increase in strains producing carbapenemase enzymes and mobile colistin resistance is now being reported, but to date there is little genomic characterization of such strains.
Introduction
Infections caused by MDR Escherichia coli are a significant global healthcare threat. 1 MDR in E. coli is largely confined to strains capable of causing extra-intestinal infections (ExPECs) such as urinary tract infections (UTIs) and bacteraemia. [1] [2] [3] [4] As many as 50% of E. coli strains isolated from UTI and bacteraemia cases may exhibit resistance to three or more classes of antibiotic, termed MDR. This resistance is primarily driven by the acquisition of large plasmids containing multiple resistance genes. 2 The rapid global dissemination of MDR E. coli is associated with carriage of plasmids containing genes encoding ESBLs that confer resistance to thirdgeneration cephalosporins. 5 The carriage of MDR plasmids containing ESBL genes renders E. coli susceptible only to the carbapenem class of antibiotics and the antimicrobial compound colistin. 5 However, strains of E. coli are now being reported with plasmids containing b-lactamases conferring resistance to carbapenems (carbapenemases) and the mcr-1 colistin resistance gene. [6] [7] [8] [9] The global dissemination of ESBL E. coli is attributable to the rapid dispersal of a small number of E. coli lineages. The most dominant of these is the ST131 lineage, which is predominantly associated with carriage of the bla CTX-M-15 ESBL gene.
2 ST131 is an ExPEC lineage and the most common cause of UTIs and bacteraemia in the developed world. 2 Other dominant lineages of ESBL E. coli are ST73, ST95 and ST648, which are also ExPECs. 3, 4 ESBL carriage can also be found transiently in strains belonging to the ST10 clonal complex of E. coli.
3 ST10 complex strains are host-generalist E. coli that are frequently found as intestinal commensal inhabitants of mammals and avian species, 10 and are devoid of the virulence-associated genes known to be required for pathogenesis. 11 Our knowledge of the genomic landscape of carbapenemase production in E. coli is far less developed, with the vast majority of reports describing genomes of individual clinical isolates sporadically distributed across the globe. Just one significant publication exists reporting a specifically designed genomic analysis of a temporal collection of carbapenem-resistant E. coli that showed very wide dissemination of carbapenem resistance across species and within-species lineages of the Enterobacteriaceae. 12 Here, we report the isolation of E. coli containing the carbapenem resistance gene bla NDM-5 in an ICU ward in West China Hospital, Chengdu. The isolates do not belong to one of the dominant MDR lineages of ExPECs, but to ST167 and ST617, both members of the ST10 clonal complex. Genomic data support the long-term presence of these bacteria in the ICU, with repeated dissemination from a central reservoir. Contextualization of the Chinese strains with a collection of publicly available genomes shows isolation of MDR ST167 and ST617 strains from clinical episodes across the world, and in the case of ST167 frequent occurrence of carriage of both ESBL and carbapenemase genes. By comparing these lineages with a large number of publicly available ST10 genomes we identify potentially significant events in their evolutionary trajectories, including mutations in the LPS biosynthesis locus that truncate LPS. We also find evidence of compensatory mutations in intergenic regions as found in E. coli ST131 as well as mutations in anaerobic metabolism loci. Our findings support the need for a more concerted global surveillance effort focusing on identifying frequently occurring lineages of carbapenem-resistant E. coli.
Methods

Bacterial isolation and characterization
Strain 0215 was recovered from a rectal swab of a 75-year-old patient in September 2013 in a 50 bed medical ICU at West China Hospital, Chengdu, during the routine screening that is performed as standard in the ICU on all new admissions. During a 7 month period from May to November 2014, bla NDM-5 -positive E. coli were recovered from the rectal swabs of eight different patients (Table S1 , available as Supplementary data at JAC Online) from a total of 560 patients admitted to the ICU during this period. Furthermore, one of the eight patients developed bacteraemia during his ICU stay and an E. coli was recovered from his blood and included in the study. During the study period, two additional E. coli clinical isolates carrying bla NDM-5 were recovered in the hospital, from two patients on admission. Rectal swabs were collected from patients within 2 days of admission to the ICU and within the 3 days prior to ICU discharge for those patients with a length of stay of 3 days. Swabs were transferred to the laboratory in transport media and were screened for carbapenem-resistant Enterobacteriaceae (CRE) using CHROMAgar Orientation agar plates containing 2 mg/L meropenem.
Ethics
This study was conducted in accordance with the amended Declaration of Helsinki and was approved, under a waiver of consent, by the Ethics Committee of West China Hospital. Rectal swabs were collected from patients within 2 days of admission to the ICU and within the 3 days prior to ICU discharge for those patients with a length of stay of 3 days.
Genome sequencing
The ST167 and ST617 strains isolated in Chengdu were cultured in LB broth at 37 C overnight. DNA was extracted using a QIAamp V R DNA Mini Kit (Qiagen) and 150 bp paired-end libraries of each strain prepared and sequenced using the Illumina HiSeq X Ten platform (raw data accession numbers are in Table S2 and S3). Genomes were assembled using SPAdes 13 and annotated using Prokka. 14 The MLST sequence type of the strains was determined using the in silico prediction tool MLSTFinder. 15 The E. coli genome database Enterobase (https://enterobase.warwick.ac.uk/) was interrogated on 1 December 2016 and all available ST167 and ST617 genomes were downloaded (Table S2 and S3) and annotated using Prokka. A further 256 ST10 genomes were selected to represent the geographical, temporal and source attribution diversity present in the database (Table S4) and were downloaded and annotated using Prokka. To select these genomes a phylogenetic tree was inferred from the assembled genome of every ST10 on Enterobase using Parsnp. 16 From this phylogeny 500 genomes were chosen to span the entire phylogenetic diversity, and then the final selection was made to represent the full ST10 diversity as described. The antibiotic resistance gene profile of all isolates was determined using Abricate (https://github.com/tseemann/abricate).
High-resolution SNP analysis
We created a closed genome sequence for a Chinese ST167 strain, 1237, by combining our Illumina sequence data with data generated on the MinIon sequencer. Raw MinIon reads were converted into fastQ format (accession number PRJNA422975) using Poretools 17 and assembled using Canu, 18 resulting in a single-contig chromosome and four distinct single-contig plasmids. The raw Illumina data were then used to polish the genome assembly via five iterative rounds of polishing with Pilon. 19 The ST167 and ST617 genomes from Chengdu were analysed by mapping raw reads against the hybrid assembled ST167 genome. Mapping was performed using Snippy (https://github.com/tseemann/snippy) and the resulting SNP profiles were used to create a consensus sequence for each genome, which was aligned using the Parsnp alignment tool in Harvest. 16 Analysis of the plasmid containing the bla NDM-5 gene revealed that it was a 47 kb IncX3 plasmid and there were no antibiotic resistance genes other than bla NDM-5 located on the plasmid. Specific mapping of the raw Illumina data against the pNDM5 plasmid was performed for all strains as described above.
Phylogenetic analysis
Pan-genomes were constructed for the ST167, ST617, ST10 and combined data sets using Roary 20 with the -e -mafft setting to create a concatenated alignment of core CDSs. The alignments were used to infer ST167, ST617, ST10 and combined phylogenies using RaxML 21 with the GTR-Gamma model of site heterogeneity and 100 bootstrap iterations. Carriage of ESBL and carbapenemase genes was annotated on the trees using Phandango (https://jameshadfield.github.io/phandango/), and geographical source was annotated using iTOL. 22 
Detection of lineage-specific genetic traits
Microbial genome-wide association (GWAS) was performed using two approaches. First the combined data set pan-genome matrix was used as input for Scoary, 23 searching for loci unique to ST167, ST617 and both ST167 and ST617 versus ST10. In parallel we also used SEER 24 to detect k-mers significantly associated with ST167, ST617 or both combined versus ST10. The results of both approaches were combined to identify coding loci associated with the emergence of ST167 and ST617. In silico serotyping was performed using two independent methods, SRST2 and SerotypeFinder. 25, 26 Both methods utilize WGS data assign to specific O and H antigens to strains. Intergenic regions (IGRs) were investigated using Piggy 27 to search for IGRs which had switched 28 in ST617, ST167, or both compared with ST10. These data were combined with SEER data to identify high-confidence IGR switches associated with the emergence of ST167 and ST617.
Results
Presence of E. coli ST167 and ST617 strains containing the NDM-5 carbapenemase resistance gene in an ICU ward in West China Hospital A total of 10 isolates of E. coli containing bla NDM-5 were obtained during the investigation. Nine of these isolates belonged to sequence types ST167/617 (Table S1 ), which are members of the ST10 complex of E. coli most commonly associated with mammalian intestinal commensal carriage. Three ST167 isolates (0215, Carbapenem-resistant clones of E. coli JAC 243 and 25) were obtained from swabs or clinical samples collected on admission to hospital, suggesting that they were introduced from external sources. The three patients were all citizens of Chengdu city but they were admitted to different local hospitals before transferring to West China Hospital. The remaining ST167 isolates were recovered from swabs or samples collected at least 3 days after admission to the ICU of West China Hospital, from patients whose initial swabs were CRE negative, indicating that they were acquired during their ICU stay. ST167 E. coli carrying bla NDM-5 caused infections (bacteraemia and abdominal infection) in only two patients but colonized the others. Both ST617 E. coli carrying bla NDM-5 only colonized patients. All patients colonized or infected with E. coli carrying bla NDM-5 of ST167 or ST617 had received carbapenems before the recovery of the isolates.
SNP analysis suggests continued dissemination of strains from a central reservoir and sharing of resistance plasmid between lineages
To determine the level of relatedness between all isolated strains we mapped reads of all the strains against a closed ST167 strain (strain 1237) generated by a combination of Illumina and MinIon sequence data. The resulting high-resolution SNP alignment showed the distance between the ST167 and ST617 strains to be .25000 SNPs, confirming they are distinct lineages, with the two ST617 isolates separated by just 7 SNPs. Deeper analysis of the ST167 cluster of strains showed diversity ranging from 5 to 799 SNPs (Figure 1 ). Strains 936 and 1222 (both carriage isolates) are the most closely related isolates, differing by just five SNPs, with both strains being acquired by patients in the ICU within 1 month of each other. However, these strains are 73 SNPs different from a strain isolated in the exact same month on the ICU from a strain (1237) that was acquired in the ICU. This is almost double the genetic distance (46 SNPs) from two strains acquired (442 and 57, isolated from the same patient) in the ICU 2 months earlier. These distances are also larger than those for any isolate to the first two strains brought into the ICU, strain 0215 and strain 243, which differ from all other isolates by around 30 SNPs, and from each other by 15 SNPs. Such an observation suggests a potential combination of patient-to-patient transmission in the affected ICU, 29 along with the continued dissemination of the strain from a central reservoir where there is an accumulation of diversity. 29, 30 Genomic analysis also allows us to identify a second introgression of an ST167 strain (25) Zong et al.
confirmed that the plasmid present in the ST617 strains was identical to that in all of the ST167 strains, with just two detectable SNPs difference across the isolates.
MDR ST167 and ST617 E. coli have been isolated across the world
We sought to contextualize the wider relevance of our Chengdu isolates by investigating the wider prevalence of ST167 and ST617 strains. We searched the Enterobase E. coli database and recovered a total of 87 genomes of ST167 (Table S2 ) and 86 genomes of ST617 (Table S3) Evolutionary genomic analysis correlates switches in LPS gene content with the emergence of the ST167/ ST617 lineage Both ST167 and ST617 are single-locus variants of the ST10 lineage of E. coli. ST10 is the most abundant lineage of E. coli represented in the Enterobase database and contains isolates ranging from drugsusceptible environmental and human commensal strains to MDR strains isolated from human clinical UTIs and bacteraemia infections. We selected 256 ST10 genomes from Enterobase (Table S4) to represent the known spectrum of ST10 diversity present in the database and merged this data set with our publicly available ST167/ ST617 genome data set to create a larger ST10 complex phylogeny ( Figure S1 ). The resulting phylogeny shows that ST167 and ST617 are sister clades with respect to ST10, with ST617 emerging as a Carbapenem-resistant clones of E. coli JAC nested clade from a single outlying ST167 genome, though the distance between ST167 and ST617 is around 18000 SNPs. Given the phylogenetic pattern of ST167 and ST617 with respect to ST10, we sought to determine whether their emergence from ST10 is associated with defined evolutionary events. We used a combined GWAS approach to compare the ST167/617 genomes with ST10, using both SEER and Scoary analysis of a pan-genome matrix. Only loci considered to be significantly associated with one lineage over the other by both methods were further investigated (Dataset S1). Most striking was the absence of the wzzB gene and wca biosynthetic cluster in ST167/ST617 whilst the majority of the ST10 genomes contained both ( Figure S2 ). These genes are involved in LPS biosynthesis, with wzzB being the master controller of O antigen chain length in the wzx/wzy pathway, whilst wca genes are responsible for colanic acid biosynthesis. 31 In silico E. coli serotyping 32 established that ST167 and ST617 demonstrate the exact same O antigenic type (O32novel) with similarity also seen in H antigen type (H9 or H10) ( Figure S2 ), whilst the SerotypeFinder database identified the strains as O89.
Our combined GWAS analysis also identified another 90 CDSs which were present across the entire data set, but which had distinct alleles in the ST167/ST617 genomes compared with those in ST10 (Figure 3 and Dataset S1). Many of these CDSs encode dehydrogenase enzymes involved in anaerobic metabolism, or are part of the cob/pdu/eut operons known to be involved in anaerobic respiration during intestinal inflammation. 33 This would appear to suggest differential evolutionary events in key genes involved in anaerobic metabolism in the formation of the ST167/ST617 lineage. Also present were unique alleles in core CDSs involved in acid and bile salt tolerance, and a number of fimbria-like proteins. In conjunction these data would suggest differential evolutionary forces acting on loci involved in mammalian colonization in ST167/617 in comparison with ST10. Furthermore, a combined SEER and Piggy approach identified unique sequences in 17 IGRs upstream of core CDSs in ST167/617 that were distinct from ST10, including IGRs upstream of anaerobic metabolic loci also present in the SEER/ Scoary analysis (Dataset S1). Zong et al.
Discussion
Our data presented here provide a comprehensive genomic analysis of two lineages of carbapenem-resistant E. coli infecting multiple patients within an ICU of West China Hospital. Both these lineages, ST167 and ST617, are members of the larger ST10 complex of E. coli, which is ubiquitously found in environmental, human clinical, and mammalian intestinal commensal sampling. To our knowledge, our analysis is the first genome-level characterization of strains belonging to ST167 or ST617, despite a number of singlesite reports of clinical infections with both lineages existing in the literature. Our analysis shows that the diversity that accumulates in the genome of the ST167 isolates during the course of the investigation is not mirrored by diversity in the plasmid carrying the bla NDM-5 gene. Only one SNP difference existed between the sequence of this plasmid in the ST167 isolates, and only two SNPs differed between the ST167 and ST617 isolates. As a result it is impossible to tell whether the IncX3 plasmid associated with dissemination of bla NDM-5 in China 34 was transferred between ST167 and ST617 in the hospital, or if the plasmid is highly stable, with only deleterious mutations occurring, and quickly purged from the population. Clearly there is a need for more thorough and detailed analysis of various resistance plasmids within and between hospitals, such as was done recently for NDM-1 plasmids in Latin America. 35 The lack of an appropriately designed isolate collection and sequencing strategy means it is impossible to conduct any form of genomic epidemiological analyses of these E. coli lineages beyond our Chinese investigation. However, the ready availability of a large number of good-quality, curated genome assemblies in the Enterobase genome database does allow us to delve deeper into the evolutionary history of E. coli ST167 and ST617. Whilst data generated and uploaded to Enterobase is prone to a bias towards clinical MDR strains, it is still clear that ESBL and carbapenem-resistant strains of both these lineages have been isolated from across the world over the past 20 or so years (Tables S1 and S2) .
Comparative genomic analysis and GWAS for traits specific to ST167 and ST617 compared with ST10 also support emergence along a shared evolutionary branch. Key among these is the complete loss of the wca operon encoding colanic acid biosynthesis in the LPS biosynthesis pathway. The majority of E. coli produce their LPS utilizing the O unit translocation pathway encoded by wzx and wzy. 31 This method utilizes glycosyltransferases to assemble the O antigen in units at the cytoplasmic membrane. These units are then translocated by Wzx and polymerized by Wzy until the O antigen chain length is reached. This mechanism is utilized by the majority of the ST10 isolates; however, genomic analysis shows that ST167 and ST617 utilize an alternative wzm/wzt ATP transporter pathway. This biosynthetic pathway assembles the entire O antigen on the cytoplasmic face before Wzt transports the O chain across the membrane, 31 resulting in an O antigen with truncated chain length. Chain length of the O antigen plays a major role in pathogenicity of Gram-negative organisms, and it has been demonstrated that loss of long O antigen chains in Salmonella optimizes immune evasion and allows successful colonization. 36 Alongside the LPS genetic changes, we also observed unique alleles of anaerobic metabolism genes and genes potentially involved in host colonization in ST167/617 compared with ST10.
Recent modelling data have shown that any factor influencing the ability of a bacterium to colonize a host will also influence its likelihood of evolving antimicrobial resistance. 37 
Conclusions
To our knowledge, we provide data from the first single-hospital genomic analysis of clinical isolates of carbapenem-resistant E. coli belonging to the ST167/617 lineage. The data presented here provide evidence for evolutionary events that would affect microbial interaction with a mammalian host underpinning the emergence of the ST167/617 lineage from ST10. There is also evidence for lineagespecific alterations in intergenic regions in ST167/617, a phenomenon that has already been described as underpinning the emergence of MDR plasmid-containing E. coli ST131 strains. 28 Clearly there is now a need for a fully designed genomic epidemiological investigation of lineages of E. coli associated with carriage of carbapenem resistance plasmids arising from the ST10 clade, both in China and internationally. Such a study will fully inform us of any potential parallelism in the evolution of MDR lineages of E. coli, and of the true nature and scope of their prevalence and global dissemination.
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